- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01494246
Effectiveness of an E-mail Tracking Intervention Among the Continued Abstinence of Tobacco Consumption (TABATIC)
Effectiveness of an E-mail Tracking Intervention Among the Continued Abstinence of Tobacco Consumption (TABATIC). A Randomized Controlled Multicentric Trial
Objectives. To evaluate the effectiveness and cost effectiveness of clinical practice guide based intervention with two face-to-face visits and e-mail tracking compared to brief advice to obtain continued smoking abstinence at 6 and 12 months after intervention.
Methodology. simple randomized controlled multicentric trial. All smokers (N=1064) aged 18 or older that attend by any reason to the primary care center and that have an e-mail account and they checked it at least once a week will be invited to participate. The enrolled participants will be randomly divided into control (N=532) and intervention group (N=532). An intensive intervention, based on the recommendations of the clinical practice guides, that will include six contacts (2 face-to-face and 4 by e-mail) will be applied to the intervention group. Control group will receive brief advice.
The main dependent variable will be continued abstinence of tobacco consumption at six and twelve months after the beginning of the intervention which will be validated by and a carbon monoxide breathe analysis measured by a cooximeter in standard conditions. Secondary variables will include: stage change on the quitting smoking process and evaluation of the effectiveness on the reduction of the number of smoked cigarettes at six and twelve months after intervention. A descriptive analysis of all variables will be done. A multivariate analysis will be undertaken to assess differences among intervention and control group; logistic regression for dichotomic variables and lineal regression for continuous variables.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Anticipated)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
-
Barcelona, Spain, 08007
- Jordi Gol i Gurina Foundation. Research Unit of Barcelona. Lifestyles Research Group.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Smokers over 18 years old with an e-mail account who use frequently. (Smoker is an individual who smokes any amount of tobacco, whatever this amount it is.
- E-mail regular user is the one who uses it as a way of communication at least once per week)
Exclusion Criteria:
- Not regular e-mail users,
- patients who have diseases that advise not to stop smoking:
- Terminal diseases
- Serious psychiatric disorders
- Active addiction to other psychoactive drugs
- Patients in smoking cessation process
- whatever the cause that does not allow to understand goals and methodology of the study
Study Plan
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: electronic mail
|
Some e-mail will be sent to participants who will be in the intervention group in order to intensify the brief advise received for stop smoking.
Other Names:
|
No Intervention: brief advise
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in smoking status and maintenance in smoking cessation
Time Frame: the outcome measure is studied at 6 and 12 months
|
The term used to name long term abstinence over 6 months is continuous abstinence.
|
the outcome measure is studied at 6 and 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
point prevalence abstinence
Time Frame: the outcome measure is studied at 3, 6 and 12 months
|
In case ok not reaching abstinence, will be measured if a subject has changed of stage in "transtheoretical model of Prochaska and DiClemente".
|
the outcome measure is studied at 3, 6 and 12 months
|
self-reported tobacco consumption
Time Frame: the outcome measure is studied at 3, 6 and 12 months
|
the outcome measure is studied at 3, 6 and 12 months
|
|
self-reported smoking reduction
Time Frame: the outcome measure will be studied at 3, 6 and 12 months
|
In case not reaching abstinence
|
the outcome measure will be studied at 3, 6 and 12 months
|
stage of change in Prochaska cycle
Time Frame: the outcome measure will be studied at 3,6 and 12 months
|
the outcome measure will be studied at 3,6 and 12 months
|
|
used time by professionals to achieve patients stop smoking
Time Frame: the outcome measure will be studied at 3, 6 and 12 months
|
the outcome measure will be studied at 3, 6 and 12 months
|
|
used time by participants
Time Frame: the outcome measure will be studied at 3, 6 and 12 months
|
the outcome measure will be studied at 3, 6 and 12 months
|
|
cost to get smoking help in primary care service
Time Frame: the outcome measure will be studied at 3, 6 and 12 months
|
The estimated cost of helping people to leave smoking in regular conditions
|
the outcome measure will be studied at 3, 6 and 12 months
|
Collaborators and Investigators
Collaborators
Investigators
- Study Chair: José L Ballvé Moreno, MD, Institut Català de la Salut
- Study Chair: Marc Casajuana, Economist, IDIAP Jordi Gol
- Study Chair: Lourdes Clemente, MD, Servicio Aragones De Salud
- Principal Investigator: Laura Díaz Gete, MD, Institut Català de la Salut
- Study Chair: Elena M Briones Carrió, Statistician, IDIAP Jordi Gol
- Study Chair: Mireia Fàbregas Escurriola, MD, Institut Català de la Salut
- Study Chair: Elisa Puigdomènech Puig, Byologist, IDIAP Jordi Gol
- Study Chair: José L del Val, MD, Institut Català de la Salut
- Study Chair: Soraya Fernández Maestre, nurse, Institut Català de la Salut
- Study Chair: Carlos Martín Cantera, MD, Ph D, Institut Català de la Salut. Research Unit of Barcelona, IDIAP Jordi Gol. Department of Medicine, University Autonomus of Barcelona
- Study Chair: Ricardo Almon, MD, PhD, Family Medicine Research centre School of Health and medical Sciences. Örebro University
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PI11/00817
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tobacco Dependence
-
Washington University School of MedicineNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Nicotine Dependence | Tobacco Dependence | Smoking, Tobacco | Nicotine Use Disorder | Nicotine Dependence, Cigarettes | Smoking, Cigarette | Nicotine Dependence Tobacco Product | Tobacco; Use, Rehabilitation | Smoking (Tobacco) Addiction and other conditionsUnited States
-
Juul Labs, Inc.Rose Research Center, LLCCompletedTobacco Use | Tobacco Smoking | Nicotine Dependence, Other Tobacco ProductUnited States
-
Juul Labs, Inc.CelerionCompletedTobacco Use | Smoking, Tobacco | Nicotine Dependence, Other Tobacco ProductUnited States
-
University of Nevada, RenoNot yet recruitingTobacco Dependence Caused by CigarettesUnited States
-
Centro Hospitalar Lisboa OcidentalCompleted
-
Juul Labs, Inc.CompletedTobacco Use | Tobacco Smoking | Nicotine Dependence | Nicotine Dependence, CigarettesNew Zealand
-
Medical University InnsbruckCompletedSubstance Abuse | Nicotine Dependence | Tobacco Dependence | Substance DependenceAustria
-
Juul Labs, Inc.CompletedTobacco Use | Tobacco Smoking | Nicotine Dependence | Nicotine Dependence, CigarettesNew Zealand
-
Assistance Publique - Hôpitaux de ParisRecruitingAdults (Male and Female Subjects) With Tobacco DependenceFrance
-
University of Wisconsin, MadisonCompleted
Clinical Trials on electronic mail
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingLynch Syndrome | Hereditary Breast Carcinoma | Hereditary Ovarian CarcinomaUnited States
-
University of ZurichMakoraCompleted
-
City of Hope Medical CenterNational Cancer Institute (NCI)WithdrawnLung Non-Small Cell Carcinoma | Lung Carcinoid Tumor | Caregiver | Lobectomy Patient
-
Universitätsklinikum Hamburg-EppendorfCompleted
-
Hospital Italiano de Buenos AiresRecruitingReminder Systems | No-Show PatientsArgentina
-
Centre Hospitalier Universitaire de NīmesCompletedPregnancy, MultipleFrance
-
Minnesota Department of HealthCompletedBreast Cancer | Colorectal CancerUnited States
-
University of Colorado, DenverAgency for Healthcare Research and Quality (AHRQ)CompletedImmunization RatesUnited States
-
Kaiser PermanenteNational Cancer Institute (NCI); University of Washington; University of Texas...CompletedNeoplasms | Urogenital Neoplasms | Neoplasms by Site | Cervical Cancer | Uterine Neoplasms | Genital Neoplasms, Female | Uterine Cervical Diseases | Uterine Diseases | HPV-Related Malignancy | HPV Infection | HPV-Related Cervical Carcinoma | Human Papilloma Virus | Uterine Cervical Neoplasm | Cervical DysplasiaUnited States
-
University of British ColumbiaBritish Columbia Cancer AgencyCompleted